Takeda Pharmaceutical Company: Upcoming launches and data readouts signal a major inflection point for growth and innovation
Leadership transition is underway with a new CEO set to unveil strategy at December's Capital Markets Day. Key launches include ORZEYFUL for narcolepsy and zasocitinib for psoriasis and IBD, with robust clinical data and competitive pricing strategies supporting rapid market penetration.Based on Ta…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.